XLO

XILIO THERAPEUTICS INC

XLO·98422T209·US·Common Stock-13D/G

XLO (XILIO THERAPEUTICS INC) is held by 14 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.7M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($1.1M), RENAISSANCE TECHNOLOGIES LLC ($614,586). Net institutional sentiment: Mixed.

14
Holders
$5.1M
Total Value
59% (17)
Consensus
10 buying - 7 selling
13F: Insider & Congress: Updated regularly
XLO

Smart Money Verdict

View all
Loading verdict
Held by 14 funds

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Jun 18, 2025 · Activists Aug 14, 2026 · Congress none

ActivistSTStemPoint Capital LP9.5%Aug 14, 2026
ActivistBIBCLS II Equity Opportunities, LP10.0%May 15, 2026
ActivistOAORBIMED ADVISORS LLC10.0%May 15, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
178,517(+44.4%)$1.7M0.0%+3.20%
24
New
111,541$1.1M0.0%-5.53%
35
Increased
64,153(+29.4%)$614,5860.0%-13.53%
31
Decreased
56,954(-0.9%)$545,6190.0%-23.11%
0
Increased
39,055(+5.0%)$374,1740.0%-83.55%
17
New
25,950$248,6010.0%-5.53%
35
Decreased
22,594(-20.6%)$216,4510.0%+7.61%
0
New
14,544$139,3320.0%-5.53%
31
Unchanged
13,311$127,5190.0%-20.14%
0
New
8,757$83,8920.0%-5.53%
33
New
714$6,8400.0%-5.53%
24
New
115$1,1020.0%-5.53%
17
New
29$2620.0%-5.53%
17
Decreased
14(-99.7%)$1340.0%+5.30%
0
Exited
0(-100.0%)$307,4530.0%-28.35%
0
Exited
0(-100.0%)$1,9760.0%+13.91%
0
Exited
0(-100.0%)$1,0000.0%+13.91%
0
Exited
0(-100.0%)$1,7660.0%+13.91%
0
XLOXLOXILIO THERAPEUTICS INC

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used